Bridging the Gap: From Machine Learning Research to Clinical Practice

Tue Dec 14 8:30am -- 5:30pm EST @ NeurIPS 2021 (Virtual)

Call for Papers

Author Instructions:


We invite submissions describing innovative machine learning research focused on bridging the gap between machine learning research and application in clinical practice. Authors are invited to submit works that fit anywhere within the broad overview of our workshop.

We are specifically interested (but are not limited to) the following areas:

  • Procedures that bring humans-in-the-loop for auditing ML healthcare systems to improve human performance, machine performance, or both.

  • Methods that are robust to changes in population, distribution shifts, or other types of biases.

  • Properties of ML methods/systems to be fulfilled to successfully deploy them in the clinic where the feasibility of these properties should also be taken into account.

  • Analyses of how to assess the failure modes of ML models for healthcare and reduce over-reliance.

  • Developing methods for improved interpretability of ML predictions in the context of healthcare.

  • Translational and implementational aspects: challenges and lessons learned from integrating an ML system into clinical workflow.


In order to make theoretical machine learning research actionable in clinical practice, we especially encourage contributions from application areas that tackle minority data groups and thus, have their own unique challenges; for example, paediatrics, critical care (ICU), rare diseases like Alzheimers, HIV, fertility, and others. To incentivise high-quality submissions of novel work, which should be compelling and highly relevant to research and clinics, we will be awarding Best Paper and Top Reviewer Awards.


Important Dates:

  • Submission Deadline: Sep 17, 2021 extended to Oct 7, 2021, Anywhere on Earth

  • Author Notification: Oct 22, 2021

Submission Files and URL:

We invite submissions relevant to the workshop and encourage contributions to any of the topics listed above. In addition, works in progress are encouraged. We will follow the same style formatting instructions as the main NeurIPS conference. There is no limit on the length of your submission, but most submissions fit into 4-8 pages (including references); the appendix can have unlimited length. Multiple reviewers will provide feedback on the submission. If accepted, you will have the opportunity to revise the paper before submitting the final version.

Submissions will be double-blind, so you should submit an anonymous preprint. You must format your submission using the provided LaTeX style files. The maximum file size for submissions is 50MB. Submissions that violate the NeurIPS style (e.g., by decreasing margins or font sizes) may be rejected without further review.

Submissions to the workshop will be handled through our CMT Submission site at https://cmt3.research.microsoft.com/research2clinics2021.

Contact:

For any questions or suggestions, please contact us at: research2clinics@gmail.com

Sponsors

GlaxoSmithKline (GSK) is a science-led global healthcare company with a special purpose to improve the quality of human life by helping people do more, feel better, live longer. Every day, we help improve the health of millions of people around the world by discovering, developing and manufacturing innovative medicines, vaccines and consumer healthcare products. We are building a stronger purpose and performance culture underpinned by our values and expectations - so that together we can deliver extraordinary impact for patients and consumers.

GSK uses AI to discover transformational medicines. AI is the key to interpret genetic datasets so we can understand the 'language' of the cell and develop medicines with a higher probability of success.


We are pleased to support this award for the best paper, describing innovative machine learning research focused on bridging the gap between machine learning research and application in clinical practice.

Note:

  • GSK is not involved in the selecting the winning paper.

  • To claim the award, the lead author of the paper selected will be required to complete the appropriate brief documentation in accordance with healthcare regulatory best practice and compliance requirements.